Form 4: HCA Director Elcan Reports Major Share Reorganization

HCA Healthcare Director Patricia F. Elcan reported a significant internal reorganization of shares held by Frisco Holding II, involving the disposition and acquisition of tens of millions of common stock shares.

Summary

• Patricia F. Elcan, a Director of HCA Healthcare, Inc., filed a Form 4 reporting changes in beneficial ownership.
• On February 6, 2026, Frisco Holding II disposed of 36,629,188 shares of HCA Common Stock.
• Concurrently, Frisco Holding II acquired 36,557,141 newly issued shares of HCA Common Stock from HCA Healthcare, Inc.
• This transaction was part of a reorganization under Section 368(a) of the Internal Revenue Code and was exempt from Section 16(b) of the Securities Exchange Act of 1934 and registration requirements under Rule 16b-3.
• Following the transaction, Frisco Holding II holds 36,557,141 shares.
• Patricia F. Elcan disclaims beneficial ownership of Frisco's shares except for her pecuniary interest, which includes 1,172 shares directly and 11,971,002 shares through trusts for her children.
• Patricia F. Elcan also reported indirect beneficial ownership through Hercules Holding II (32,282,889 shares), her spouse (5,031 shares), and other trusts (147,261 shares), as well as 41,052 shares held jointly with her spouse.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event. Form 4 filings are primarily informational disclosures of insider transactions, and this specific filing details an internal share reorganization rather than a market-driven sale or purchase, thus having limited direct impact on company sentiment.

Positives

• The transaction is described as a reorganization, suggesting a strategic internal adjustment rather than a simple market sale.
• The transaction was exempt from Section 16(b) and registration requirements, indicating compliance with regulatory frameworks for internal corporate actions.

Negatives

• The net effect of the Frisco transaction is a slight reduction in the number of shares held by Frisco (a disposition of 36,629,188 shares for an acquisition of 36,557,141 shares, a net decrease of 72,047 shares).

Future Outlook

The filing does not provide explicit forward-looking statements or guidance beyond the reported transaction date.

Industry Context

StockSavvy.ai notes that Form 4 filings are routine disclosures for insiders and typically reflect internal corporate or personal financial planning rather than broader industry trends. This specific filing details a significant internal share reorganization for a major healthcare provider, HCA Healthcare, which is common for large, complex corporate structures involving founder-affiliated holding groups.

Comparison to Industry Standards

• This Form 4 reports a specific internal reorganization and ownership structure for HCA Healthcare. Direct comparisons to other companies' specific internal reorganizations are not readily available or relevant without more context on the nature of the reorganization. However, such reorganizations are not uncommon for large, established companies with complex ownership structures involving founder families or private investor groups, similar to how other large healthcare systems or diversified conglomerates might manage their equity holdings.

Corporate Governance

Related Party Transactions

• Disposition and acquisition of HCA Common Stock by Frisco Holding II, an entity held by a private investor group including affiliates of HCA Inc. founder Dr. Thomas F. Frist Jr., where the reporting person, Patricia F. Elcan, has a pecuniary interest.
• Beneficial ownership through Hercules Holding II, also held by a private investor group including affiliates of HCA Inc. founder Dr. Thomas F. Frist Jr., where Patricia F. Elcan has a pecuniary interest.

Stakeholder Impact

• Shareholders: The reorganization is an internal event for a major holding entity and does not directly impact the public float or the company's operational performance. It clarifies the beneficial ownership structure for a director.
• Regulatory Authorities: The filing ensures transparency regarding insider ownership changes and compliance with SEC regulations (Form 4, Rule 16b-3 exemption).

Key Dates

Recommendation

This Form 4 filing reports an internal share reorganization by a director's affiliated holding entity. It does not indicate a change in the company's fundamentals, operational performance, or strategic direction. While it clarifies beneficial ownership, it provides no new information to warrant a change in investment thesis, thus a 'hold' recommendation is appropriate.

Keywords

HCA Healthcare, HCA, Form 4, Beneficial Ownership, Insider Transaction, Director, Share Reorganization, Equity, SEC Filing, Patricia F. Elcan